OBJECTIVE: To provide information for clinical rational usage of ticlopidine and clopidogrel.
前言: 目的:为临床合理使用噻氯吡定和氯吡格雷提供参考。
Objective To study the action of ticlopidine in inhibiting EDTA-dependent platelet aggregation in vitro.
目的探讨噻氯匹啶在体外对EDTA依赖性血小板聚集的抑制作用。
Objective To investigate the safety and efficiency of ticlopidine and warfarin on intracardiac mural thrombus.
目的观察噻氯吡啶与华法林在治疗心腔内附壁血栓的疗效及安全性。
Preferred drugs in the order: first choice as clopidogrel, to aspirin second choice, third choice as ticlopidine.
优选药物的次序为:第一选择为氯吡格雷,第二选择为阿司匹林,第三选择为噻氯匹啶。
OBJECTIVE:To observe the efficiency and security of aspirin and ticlopidine on prevention of acute cerebral infarction .
目的:观察阿司匹林、噻氯匹啶预防急性脑梗死的疗效与安全性。
So, we need new randomized trials to answer the question if ticlopidine and aspirin are superior to aspirin alone.
因此,需要新的前瞻性临床试验来验证是否二者合用优于单用一种药物。
Ticlopidine is a new platelet aggregation inhibitor.
噻氯匹定是一种高效血小板聚集抑制剂。
Ticlopidine is a new platelet aggregation inhibitor.
噻氯匹定是一种高效血小板聚集抑制剂。
应用推荐